Avalo Therapeutics (AVTX) Institutional Ownership $9.29 -0.05 (-0.54%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$8.98 -0.31 (-3.38%) As of 08/29/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)CurrentInstitutional OwnershipPercentage87.06%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$38.86MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$3.19M Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data AVTX Institutional Buying and Selling by Quarter Avalo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Perceptive Advisors LLC139,667$697K0.1%-73.1%1.062% 8/15/2025 Boothbay Fund Management LLC11,321$56K0.0%N/A0.086% 8/15/2025 BVF Inc. IL1,028,049$5.13M0.2%-0.8%7.818% 8/15/2025 Bank of America Corp DE406,571$2.03M0.0%+7,066.8%3.092% 8/14/2025 Nantahala Capital Management LLC995,000$4.97M0.2%+10.6%7.565% 8/14/2025 Velan Capital Investment Management LP154,972$773K0.8%+38.4%1.178% 8/13/2025 Affinity Asset Advisors LLC607,872$3.03M0.4%-7.5%4.623% 8/13/2025 Quadrature Capital Ltd10,976$55K0.0%N/A0.083% 8/8/2025 Geode Capital Management LLC110,460$552K0.0%+2.5%1.020% 8/6/2025 RWA Wealth Partners LLC261,016$1.30M0.0%-16.5%2.410% Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Allostery Investments LP107,141$858K1.2%+46.1%0.989% 5/16/2025 ADAR1 Capital Management LLC10,000$80K0.0%N/A0.092% 5/15/2025 Nantahala Capital Management LLC900,000$7.21M0.3%N/A8.312% 5/14/2025 Affinity Asset Advisors LLC657,154$5.26M0.5%+19.3%6.069% 5/14/2025 RWA Wealth Partners LLC312,779$2.51M0.0%N/A2.889% 2/17/2025 Velan Capital Investment Management LP109,972$817K0.7%N/A1.058% 2/17/2025 Deep Track Capital LP867,000$6.44M0.2%-10.3%8.345% 2/17/2025 BVF Inc. IL1,036,679$7.70M0.3%+7.2%9.978% 2/17/2025 Allostery Investments LP73,314$545K0.6%N/A0.706% 2/14/2025 Northern Trust Corp22,673$168K0.0%N/A0.218% 2/14/2025 Tower Research Capital LLC TRC4,130$31K0.0%+998.4%0.040% 2/13/2025 Marshall Wace LLP15,323$114K0.0%N/A0.147% 2/13/2025 Affinity Asset Advisors LLC550,765$4.09M0.5%+1,123.9%5.299% 2/13/2025 Walleye Capital LLC19,477$145K0.0%N/A0.187% 2/13/2025 Bank of Montreal Can60,000$446K0.0%N/A0.577% 2/12/2025 Geode Capital Management LLC104,853$779K0.0%+937.0%1.009% 11/15/2024 RA Capital Management L.P.967,000$9.19M0.1%N/A93.883% 11/15/2024 Ikarian Capital LLC970,359$9.22M1.2%+1,673.0%94.210% 8/27/2024 Logos Global Management LP539,079$6.72M0.5%N/A52.135% 8/15/2024 Affinity Asset Advisors LLC45,000$561K0.1%+350.0%4.352% 5/17/2024 Ikarian Capital LLC46,648$1.02M0.1%N/A4.511% 5/15/2024 Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971% 5/14/2024 Natixis2,512$55K0.0%-45.4%0.244% 11/13/2023 Acadian Asset Management LLC283,306$34K0.0%N/A1.399% 8/11/2023 VR Adviser LLC1,250,000$444K0.1%+25.0%6.173% 5/16/2023 Great Point Partners LLC474,639$831K0.2%N/A3.595% 5/5/2023 Monashee Investment Management LLC60,000$105K0.0%N/A0.455% 2/15/2023 Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746% 11/14/2022 Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115% 11/14/2022 Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319% BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.Claim your free copy of “How to Survive the Next Financial Crisis” today11/10/2022 Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819% 10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166% 8/15/2022 Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280% 8/15/2022 Opaleye Management Inc.450,000$225K0.1%-69.1%4.780% 5/12/2022 Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621% 5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056% 4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038% 2/15/2022 Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344% 2/15/2022 LGL Partners LLC28,850$49K0.0%N/A0.026% 2/14/2022 Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018% 2/14/2022 Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686% 2/8/2022 Northern Trust Corp533,578$907K0.0%+3.1%0.475% 2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519% 1/24/2022 Strs Ohio38,400$65K0.0%-40.2%0.034% 1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031% 12/29/2021 Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176% 11/16/2021 Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299% 11/16/2021 Squarepoint Ops LLC18,657$41K0.0%N/A0.017% 11/16/2021 Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713% 11/16/2021 Two Sigma Investments LP732,931$1.60M0.0%N/A0.653% 11/16/2021 Laurion Capital Management LP330,444$720K0.0%N/A0.294% 11/15/2021 Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350% 11/15/2021 Atom Investors LP27,507$60K0.0%N/A0.024% 11/15/2021 Voya Investment Management LLC21,854$48K0.0%N/A0.019% 11/15/2021Caas Capital Management LP11,812$26K0.0%N/A0.011% 11/12/2021 Aristides Capital LLC48,953$107K0.0%N/A0.044% 11/12/2021 Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770% 11/12/2021 Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126% 11/12/2021 Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473% 11/10/2021 Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610% 11/10/2021 Creative Planning14,814$32K0.0%N/A0.013% 11/10/2021 Alliancebernstein L.P.19,100$42K0.0%N/A0.017% 11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369% 11/9/2021 Monashee Investment Management LLC270,000$589K0.1%N/A0.245% 11/8/2021 Meeder Asset Management Inc.19,260$43K0.0%N/A0.017% 11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485% 11/4/2021 Deutsche Bank AG31,794$69K0.0%N/A0.029% 11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011% 11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020% 11/2/2021 Victory Capital Management Inc.15,788$34K0.0%N/A0.014% 11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017% 10/29/2021 Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047% 10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094% 10/22/2021 Strs Ohio64,200$139K0.0%N/A0.058% 10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797% 10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021% (Data available from 1/1/2016 forward) AVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTX shares? During the previous two years, 23 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Ikarian Capital LLC ($9.22M), RA Capital Management L.P. ($9.19M), Logos Global Management LP ($6.72M), Deep Track Capital LP ($6.44M), BVF Inc. IL ($5.13M), Nantahala Capital Management LLC ($4.97M), and Affinity Asset Advisors LLC ($3.03M).Learn more on Avalo Therapeutics' institutional investors. What percentage of Avalo Therapeutics' stock is owned by institutional investors? 87.06% of Avalo Therapeutics' stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings. Which institutional investors have been buying Avalo Therapeutics' stock? Of the 20 institutional investors that purchased Avalo Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($995K), RA Capital Management L.P. ($967K), Ikarian Capital LLC ($962.28K), Affinity Asset Advisors LLC ($657.15K), Logos Global Management LP ($539.08K), Bank of America Corp DE ($400.90K), and RWA Wealth Partners LLC ($312.78K). How much institutional buying is happening at Avalo Therapeutics? Institutional investors have bought a total of 4,784,166 shares in the last 24 months. This purchase volume represents approximately $38.86M in transactions. Which of Avalo Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Perceptive Advisors LLC ($380.33K), Deep Track Capital LP ($100K), RWA Wealth Partners LLC ($51.76K), Affinity Asset Advisors LLC ($49.28K), and BVF Inc. IL ($8.63K). How much institutional selling is happening at Avalo Therapeutics? Institutional investors have sold a total of 590,008 shares in the last 24 months. This volume of shares sold represents approximately $3.19M in transactions. Related Companies Alumis Institutional Ownership Arcturus Therapeutics Institutional Ownership Evolus Institutional Ownership Bicycle Therapeutics Institutional Ownership Tectonic Therapeutic Institutional Ownership Nanobiotix Institutional Ownership Cullinan Therapeutics Institutional Ownership Prime Medicine Institutional Ownership Prothena Institutional Ownership Autolus Therapeutics Institutional Ownership This page (NASDAQ:AVTX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTX Stock Alerts